JPT2 and breast carcinoma: Hematological and neurological expressed 1 like (HN1L), also known as JPT2, or C16orf34, is a multifunctional oncogene that we and other groups have recently identified in lung cancer [4], hepatocellular carcinoma [5], and breast cancer [6].